Topic primer

Repair and recovery

The compounds most promoted for injury recovery have the widest gap between the volume of animal research and the volume of human trials. This topic tracks registered trials, reviews and the regulatory decisions that follow.

TIMELINE

2015

Phase I study of BPC-157 registered (NCT02637284); never reports.
Feb 2026

Phase 2 hamstring-strain trial of BPC-157 registered (NCT07437547).
23–24 Jul 2026

PCAC recommends BPC-157 and TB-500 for the 503A bulks list.

ENTRIES ON THIS TOPIC · 1

as of Oct 2026
EVIDENCE

BPC-157: what the human record contains

As of October 2026 there is no published randomised controlled trial of BPC-157 in humans. Published human data are small pilot studies; a 2015 Phase I never reported; a Phase 2 hamstring-strain trial was registered in February 2026.